| PRODUCTO |
ARTÍCULOS |
| Helistop® |
1. Significant Reduction in Helicobacter pylori Load in Humans with Non-viable Lactobacillus reuteri DMS17648: A Pilot Study
2. Non-Viable Lactobacillus reuteri DMSMZ 17648 (Pylopass™) as a New Approach to Helicobacter pylori Control in Humans
3. The efficiency and safety of probiotic bacteria Lactobacillus reuteri DSMZ17648 (HELINORM ®) in patients infected with Helicobacter pylori, who haven´t absolute indication therapy: results of the study
4. The efficacy and the safety of Lactobacillus reuteri DSMZ17648 in the treatment of Helicobacter pylori positive patient
5. An innovative approach in the treatment of H. pylori infection in children.
6. Evolution in eradication therapy of HP -associated diseases: beyond the standards?
7. The effect of Lactobacillus reuteri supplementation in Helicobacter pylori infection: a placebo-controlled, single-blind study |
